266 related articles for article (PubMed ID: 29104277)
1. Heparan Sulfate Biosynthetic System Is Inhibited in Human Glioma Due to EXT1/2 and HS6ST1/2 Down-Regulation.
Ushakov VS; Tsidulko AY; de La Bourdonnaye G; Kazanskaya GM; Volkov AM; Kiselev RS; Kobozev VV; Kostromskaya DV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29104277
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone Inhibits Heparan Sulfate Biosynthetic System and Decreases Heparan Sulfate Content in Orthotopic Glioblastoma Tumors in Mice.
Sokolov DK; Shevelev OB; Khotskina AS; Tsidulko AY; Strokotova AV; Kazanskaya GM; Volkov AM; Kliver EE; Aidagulova SV; Zavjalov EL; Grigorieva EV
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373391
[TBL] [Abstract][Full Text] [Related]
3. Tissue-specificity of heparan sulfate biosynthetic machinery in cancer.
Suhovskih AV; Domanitskaya NV; Tsidulko AY; Prudnikova TY; Kashuba VI; Grigorieva EV
Cell Adh Migr; 2015; 9(6):452-9. PubMed ID: 26120938
[TBL] [Abstract][Full Text] [Related]
4. Heparan Sulfate Glycosaminoglycans in Glioblastoma Promote Tumor Invasion.
Tran VM; Wade A; McKinney A; Chen K; Lindberg OR; Engler JR; Persson AI; Phillips JJ
Mol Cancer Res; 2017 Nov; 15(11):1623-1633. PubMed ID: 28778876
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate biosynthesis enzymes EXT1 and EXT2 affect NDST1 expression and heparan sulfate sulfation.
Presto J; Thuveson M; Carlsson P; Busse M; Wilén M; Eriksson I; Kusche-Gullberg M; Kjellén L
Proc Natl Acad Sci U S A; 2008 Mar; 105(12):4751-6. PubMed ID: 18337501
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate accumulation and perlecan/HSPG2 up-regulation in tumour tissue predict low relapse-free survival for patients with glioblastoma.
Kazanskaya GM; Tsidulko AY; Volkov AM; Kiselev RS; Suhovskih AV; Kobozev VV; Gaytan AS; Aidagulova SV; Krivoshapkin AL; Grigorieva EV
Histochem Cell Biol; 2018 Mar; 149(3):235-244. PubMed ID: 29322326
[TBL] [Abstract][Full Text] [Related]
7. Chondrocytes respond to an altered heparan sulfate composition with distinct changes of heparan sulfate structure and increased levels of chondroitin sulfate.
Bachvarova V; Dierker T; Esko J; Hoffmann D; Kjellen L; Vortkamp A
Matrix Biol; 2020 Nov; 93():43-59. PubMed ID: 32201365
[TBL] [Abstract][Full Text] [Related]
8. Tinkering with heparan sulfate sulfation to steer development.
Gorsi B; Stringer SE
Trends Cell Biol; 2007 Apr; 17(4):173-7. PubMed ID: 17320398
[TBL] [Abstract][Full Text] [Related]
9. Chemoradiotherapy Increases Intratumor Heterogeneity of HPSE Expression in the Relapsed Glioblastoma Tumors.
Suhovskih AV; Kazanskaya GM; Volkov AM; Tsidulko AY; Aidagulova SV; Grigorieva EV
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075104
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of heparan sulfate 6-O-sulfation in idiopathic pulmonary fibrosis.
Lu J; Auduong L; White ES; Yue X
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):106-14. PubMed ID: 23962103
[TBL] [Abstract][Full Text] [Related]
11. Heparan sulfate in the regulation of neural differentiation and glioma development.
Xiong A; Kundu S; Forsberg-Nilsson K
FEBS J; 2014 Nov; 281(22):4993-5008. PubMed ID: 25284049
[TBL] [Abstract][Full Text] [Related]
12. Triglyceride-rich lipoprotein binding and uptake by heparan sulfate proteoglycan receptors in a CRISPR/Cas9 library of Hep3B mutants.
Anower-E-Khuda F; Singh G; Deng Y; Gordts PLSM; Esko JD
Glycobiology; 2019 Jul; 29(8):582-592. PubMed ID: 31094413
[TBL] [Abstract][Full Text] [Related]
13. An altered heparan sulfate structure in the articular cartilage protects against osteoarthritis.
Severmann AC; Jochmann K; Feller K; Bachvarova V; Piombo V; Stange R; Holzer T; Brachvogel B; Esko J; Pap T; Hoffmann D; Vortkamp A
Osteoarthritis Cartilage; 2020 Jul; 28(7):977-987. PubMed ID: 32315715
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional Activity of Heparan Sulfate Biosynthetic Machinery is Specifically Impaired in Benign Prostate Hyperplasia and Prostate Cancer.
Suhovskih AV; Tsidulko AY; Kutsenko OS; Kovner AV; Aidagulova SV; Ernberg I; Grigorieva EV
Front Oncol; 2014; 4():79. PubMed ID: 24782989
[TBL] [Abstract][Full Text] [Related]
15. NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length.
Deligny A; Dierker T; Dagälv A; Lundequist A; Eriksson I; Nairn AV; Moremen KW; Merry CLR; Kjellén L
J Biol Chem; 2016 Sep; 291(36):18600-18607. PubMed ID: 27387504
[TBL] [Abstract][Full Text] [Related]
16. Contribution of EXT1, EXT2, and EXTL3 to heparan sulfate chain elongation.
Busse M; Feta A; Presto J; Wilén M; Grønning M; Kjellén L; Kusche-Gullberg M
J Biol Chem; 2007 Nov; 282(45):32802-10. PubMed ID: 17761672
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis of heparan sulfate in EXT1-deficient cells.
Okada M; Nadanaka S; Shoji N; Tamura J; Kitagawa H
Biochem J; 2010 May; 428(3):463-71. PubMed ID: 20377530
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of heparan sulfate with cyclophilin B-binding properties is determined by cell type-specific expression of sulfotransferases.
Deligny A; Denys A; Marcant A; Melchior A; Mazurier J; van Kuppevelt TH; Allain F
J Biol Chem; 2010 Jan; 285(3):1701-15. PubMed ID: 19940140
[TBL] [Abstract][Full Text] [Related]
19. Heparan Sulfate Synthesized by
Ohkawa Y; Wade A; Lindberg OR; Chen KY; Tran VM; Brown SJ; Kumar A; Kalita M; James CD; Phillips JJ
Mol Cancer Res; 2021 Jan; 19(1):150-161. PubMed ID: 33028660
[TBL] [Abstract][Full Text] [Related]
20. Enzymatically active N-deacetylase/N-sulfotransferase-2 is present in liver but does not contribute to heparan sulfate N-sulfation.
Ledin J; Ringvall M; Thuveson M; Eriksson I; Wilén M; Kusche-Gullberg M; Forsberg E; Kjellén L
J Biol Chem; 2006 Nov; 281(47):35727-34. PubMed ID: 16984905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
